Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Sin...
Gespeichert in:
| Veröffentlicht in: | Euro surveillance : bulletin européen sur les maladies transmissibles 2008-07, Vol.13 (31) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 31 |
| container_start_page | |
| container_title | Euro surveillance : bulletin européen sur les maladies transmissibles |
| container_volume | 13 |
| creator | Kuijper, E J Barbut, F Brazier, J S Kleinkauf, N Eckmanns, T Lambert, M L Drudy, D Fitzpatrick, F Wiuff, C Brown, D J Coia, J E Pituch, H Reichert, P Even, J Mossong, J Widmer, A F Olsen, K E Allerberger, F Notermans, D W Delmée, M Coignard, B Wilcox, M Patel, B Frei, R Nagy, E Bouza, E Marin, M Akerlund, T Virolainen-Julkunen, A Lyytikäinen, O Kotila, S Ingebretsen, A Smyth, B Rooney, P Poxton, I R Monnet, D L |
| description | Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027.C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad.The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones. |
| doi_str_mv | 10.2807/ese.13.31.18942-en |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69488104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69488104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260n-e52f2144eaac655f0a738630c641c03e56f53e64d27cf2afe9c99ac787431ce83</originalsourceid><addsrcrecordid>eNpNkEtLxDAcxIMo7rr6BTxITp5szatJepSyPmDBB-45ZNN_INI2tWkP--2tuqCnmcPMwPwQuqQkZ5qoW0iQU55zmlNdCpZBd4SWtJAkUyVVx__8Ap2l9EGI4KRkp2hBtZK0JHyJXrd9bUfA0eOqiWkcQh2mFtfB--BCAzh0HtwYYofrCfAY8Uv1hoewi-O-B0yYmhN4PQ2xhxvMCNHn6MTbJsHFQVdoe79-rx6zzfPDU3W3yRyTpMugYJ5RIcBaJ4vCE6u4lpw4KagjHArpCw5S1Ew5z6yH0pWldUorwakDzVfo-ne3H-LnBGk0bUgOmsZ2EKdkZCm0pvPlFWK_QTfElAbwph9Ca4e9ocR8gzQzSEO54dT8gDTQzaWrw_q0a6H-qxzI8S_AR24S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69488104</pqid></control><display><type>article</type><title>Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kuijper, E J ; Barbut, F ; Brazier, J S ; Kleinkauf, N ; Eckmanns, T ; Lambert, M L ; Drudy, D ; Fitzpatrick, F ; Wiuff, C ; Brown, D J ; Coia, J E ; Pituch, H ; Reichert, P ; Even, J ; Mossong, J ; Widmer, A F ; Olsen, K E ; Allerberger, F ; Notermans, D W ; Delmée, M ; Coignard, B ; Wilcox, M ; Patel, B ; Frei, R ; Nagy, E ; Bouza, E ; Marin, M ; Akerlund, T ; Virolainen-Julkunen, A ; Lyytikäinen, O ; Kotila, S ; Ingebretsen, A ; Smyth, B ; Rooney, P ; Poxton, I R ; Monnet, D L</creator><creatorcontrib>Kuijper, E J ; Barbut, F ; Brazier, J S ; Kleinkauf, N ; Eckmanns, T ; Lambert, M L ; Drudy, D ; Fitzpatrick, F ; Wiuff, C ; Brown, D J ; Coia, J E ; Pituch, H ; Reichert, P ; Even, J ; Mossong, J ; Widmer, A F ; Olsen, K E ; Allerberger, F ; Notermans, D W ; Delmée, M ; Coignard, B ; Wilcox, M ; Patel, B ; Frei, R ; Nagy, E ; Bouza, E ; Marin, M ; Akerlund, T ; Virolainen-Julkunen, A ; Lyytikäinen, O ; Kotila, S ; Ingebretsen, A ; Smyth, B ; Rooney, P ; Poxton, I R ; Monnet, D L</creatorcontrib><description>Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027.C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad.The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones.</description><identifier>ISSN: 1560-7917</identifier><identifier>EISSN: 1560-7917</identifier><identifier>DOI: 10.2807/ese.13.31.18942-en</identifier><identifier>PMID: 18761903</identifier><language>eng</language><publisher>Sweden</publisher><subject>Clostridium difficile - genetics ; Clostridium difficile - pathogenicity ; Disease Outbreaks ; Enterocolitis, Pseudomembranous - epidemiology ; Europe - epidemiology ; European Union ; Humans ; Polymerase Chain Reaction ; Population Surveillance ; Ribotyping</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2008-07, Vol.13 (31)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260n-e52f2144eaac655f0a738630c641c03e56f53e64d27cf2afe9c99ac787431ce83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,865,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18761903$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuijper, E J</creatorcontrib><creatorcontrib>Barbut, F</creatorcontrib><creatorcontrib>Brazier, J S</creatorcontrib><creatorcontrib>Kleinkauf, N</creatorcontrib><creatorcontrib>Eckmanns, T</creatorcontrib><creatorcontrib>Lambert, M L</creatorcontrib><creatorcontrib>Drudy, D</creatorcontrib><creatorcontrib>Fitzpatrick, F</creatorcontrib><creatorcontrib>Wiuff, C</creatorcontrib><creatorcontrib>Brown, D J</creatorcontrib><creatorcontrib>Coia, J E</creatorcontrib><creatorcontrib>Pituch, H</creatorcontrib><creatorcontrib>Reichert, P</creatorcontrib><creatorcontrib>Even, J</creatorcontrib><creatorcontrib>Mossong, J</creatorcontrib><creatorcontrib>Widmer, A F</creatorcontrib><creatorcontrib>Olsen, K E</creatorcontrib><creatorcontrib>Allerberger, F</creatorcontrib><creatorcontrib>Notermans, D W</creatorcontrib><creatorcontrib>Delmée, M</creatorcontrib><creatorcontrib>Coignard, B</creatorcontrib><creatorcontrib>Wilcox, M</creatorcontrib><creatorcontrib>Patel, B</creatorcontrib><creatorcontrib>Frei, R</creatorcontrib><creatorcontrib>Nagy, E</creatorcontrib><creatorcontrib>Bouza, E</creatorcontrib><creatorcontrib>Marin, M</creatorcontrib><creatorcontrib>Akerlund, T</creatorcontrib><creatorcontrib>Virolainen-Julkunen, A</creatorcontrib><creatorcontrib>Lyytikäinen, O</creatorcontrib><creatorcontrib>Kotila, S</creatorcontrib><creatorcontrib>Ingebretsen, A</creatorcontrib><creatorcontrib>Smyth, B</creatorcontrib><creatorcontrib>Rooney, P</creatorcontrib><creatorcontrib>Poxton, I R</creatorcontrib><creatorcontrib>Monnet, D L</creatorcontrib><title>Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><addtitle>Euro Surveill</addtitle><description>Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027.C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad.The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones.</description><subject>Clostridium difficile - genetics</subject><subject>Clostridium difficile - pathogenicity</subject><subject>Disease Outbreaks</subject><subject>Enterocolitis, Pseudomembranous - epidemiology</subject><subject>Europe - epidemiology</subject><subject>European Union</subject><subject>Humans</subject><subject>Polymerase Chain Reaction</subject><subject>Population Surveillance</subject><subject>Ribotyping</subject><issn>1560-7917</issn><issn>1560-7917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtLxDAcxIMo7rr6BTxITp5szatJepSyPmDBB-45ZNN_INI2tWkP--2tuqCnmcPMwPwQuqQkZ5qoW0iQU55zmlNdCpZBd4SWtJAkUyVVx__8Ap2l9EGI4KRkp2hBtZK0JHyJXrd9bUfA0eOqiWkcQh2mFtfB--BCAzh0HtwYYofrCfAY8Uv1hoewi-O-B0yYmhN4PQ2xhxvMCNHn6MTbJsHFQVdoe79-rx6zzfPDU3W3yRyTpMugYJ5RIcBaJ4vCE6u4lpw4KagjHArpCw5S1Ew5z6yH0pWldUorwakDzVfo-ne3H-LnBGk0bUgOmsZ2EKdkZCm0pvPlFWK_QTfElAbwph9Ca4e9ocR8gzQzSEO54dT8gDTQzaWrw_q0a6H-qxzI8S_AR24S</recordid><startdate>20080731</startdate><enddate>20080731</enddate><creator>Kuijper, E J</creator><creator>Barbut, F</creator><creator>Brazier, J S</creator><creator>Kleinkauf, N</creator><creator>Eckmanns, T</creator><creator>Lambert, M L</creator><creator>Drudy, D</creator><creator>Fitzpatrick, F</creator><creator>Wiuff, C</creator><creator>Brown, D J</creator><creator>Coia, J E</creator><creator>Pituch, H</creator><creator>Reichert, P</creator><creator>Even, J</creator><creator>Mossong, J</creator><creator>Widmer, A F</creator><creator>Olsen, K E</creator><creator>Allerberger, F</creator><creator>Notermans, D W</creator><creator>Delmée, M</creator><creator>Coignard, B</creator><creator>Wilcox, M</creator><creator>Patel, B</creator><creator>Frei, R</creator><creator>Nagy, E</creator><creator>Bouza, E</creator><creator>Marin, M</creator><creator>Akerlund, T</creator><creator>Virolainen-Julkunen, A</creator><creator>Lyytikäinen, O</creator><creator>Kotila, S</creator><creator>Ingebretsen, A</creator><creator>Smyth, B</creator><creator>Rooney, P</creator><creator>Poxton, I R</creator><creator>Monnet, D L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080731</creationdate><title>Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008</title><author>Kuijper, E J ; Barbut, F ; Brazier, J S ; Kleinkauf, N ; Eckmanns, T ; Lambert, M L ; Drudy, D ; Fitzpatrick, F ; Wiuff, C ; Brown, D J ; Coia, J E ; Pituch, H ; Reichert, P ; Even, J ; Mossong, J ; Widmer, A F ; Olsen, K E ; Allerberger, F ; Notermans, D W ; Delmée, M ; Coignard, B ; Wilcox, M ; Patel, B ; Frei, R ; Nagy, E ; Bouza, E ; Marin, M ; Akerlund, T ; Virolainen-Julkunen, A ; Lyytikäinen, O ; Kotila, S ; Ingebretsen, A ; Smyth, B ; Rooney, P ; Poxton, I R ; Monnet, D L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260n-e52f2144eaac655f0a738630c641c03e56f53e64d27cf2afe9c99ac787431ce83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Clostridium difficile - genetics</topic><topic>Clostridium difficile - pathogenicity</topic><topic>Disease Outbreaks</topic><topic>Enterocolitis, Pseudomembranous - epidemiology</topic><topic>Europe - epidemiology</topic><topic>European Union</topic><topic>Humans</topic><topic>Polymerase Chain Reaction</topic><topic>Population Surveillance</topic><topic>Ribotyping</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuijper, E J</creatorcontrib><creatorcontrib>Barbut, F</creatorcontrib><creatorcontrib>Brazier, J S</creatorcontrib><creatorcontrib>Kleinkauf, N</creatorcontrib><creatorcontrib>Eckmanns, T</creatorcontrib><creatorcontrib>Lambert, M L</creatorcontrib><creatorcontrib>Drudy, D</creatorcontrib><creatorcontrib>Fitzpatrick, F</creatorcontrib><creatorcontrib>Wiuff, C</creatorcontrib><creatorcontrib>Brown, D J</creatorcontrib><creatorcontrib>Coia, J E</creatorcontrib><creatorcontrib>Pituch, H</creatorcontrib><creatorcontrib>Reichert, P</creatorcontrib><creatorcontrib>Even, J</creatorcontrib><creatorcontrib>Mossong, J</creatorcontrib><creatorcontrib>Widmer, A F</creatorcontrib><creatorcontrib>Olsen, K E</creatorcontrib><creatorcontrib>Allerberger, F</creatorcontrib><creatorcontrib>Notermans, D W</creatorcontrib><creatorcontrib>Delmée, M</creatorcontrib><creatorcontrib>Coignard, B</creatorcontrib><creatorcontrib>Wilcox, M</creatorcontrib><creatorcontrib>Patel, B</creatorcontrib><creatorcontrib>Frei, R</creatorcontrib><creatorcontrib>Nagy, E</creatorcontrib><creatorcontrib>Bouza, E</creatorcontrib><creatorcontrib>Marin, M</creatorcontrib><creatorcontrib>Akerlund, T</creatorcontrib><creatorcontrib>Virolainen-Julkunen, A</creatorcontrib><creatorcontrib>Lyytikäinen, O</creatorcontrib><creatorcontrib>Kotila, S</creatorcontrib><creatorcontrib>Ingebretsen, A</creatorcontrib><creatorcontrib>Smyth, B</creatorcontrib><creatorcontrib>Rooney, P</creatorcontrib><creatorcontrib>Poxton, I R</creatorcontrib><creatorcontrib>Monnet, D L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuijper, E J</au><au>Barbut, F</au><au>Brazier, J S</au><au>Kleinkauf, N</au><au>Eckmanns, T</au><au>Lambert, M L</au><au>Drudy, D</au><au>Fitzpatrick, F</au><au>Wiuff, C</au><au>Brown, D J</au><au>Coia, J E</au><au>Pituch, H</au><au>Reichert, P</au><au>Even, J</au><au>Mossong, J</au><au>Widmer, A F</au><au>Olsen, K E</au><au>Allerberger, F</au><au>Notermans, D W</au><au>Delmée, M</au><au>Coignard, B</au><au>Wilcox, M</au><au>Patel, B</au><au>Frei, R</au><au>Nagy, E</au><au>Bouza, E</au><au>Marin, M</au><au>Akerlund, T</au><au>Virolainen-Julkunen, A</au><au>Lyytikäinen, O</au><au>Kotila, S</au><au>Ingebretsen, A</au><au>Smyth, B</au><au>Rooney, P</au><au>Poxton, I R</au><au>Monnet, D L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><addtitle>Euro Surveill</addtitle><date>2008-07-31</date><risdate>2008</risdate><volume>13</volume><issue>31</issue><issn>1560-7917</issn><eissn>1560-7917</eissn><abstract>Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027.C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad.The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones.</abstract><cop>Sweden</cop><pmid>18761903</pmid><doi>10.2807/ese.13.31.18942-en</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1560-7917 |
| ispartof | Euro surveillance : bulletin européen sur les maladies transmissibles, 2008-07, Vol.13 (31) |
| issn | 1560-7917 1560-7917 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69488104 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | Clostridium difficile - genetics Clostridium difficile - pathogenicity Disease Outbreaks Enterocolitis, Pseudomembranous - epidemiology Europe - epidemiology European Union Humans Polymerase Chain Reaction Population Surveillance Ribotyping |
| title | Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T22%3A54%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20of%20Clostridium%20difficile%20infection%20due%20to%20PCR%20ribotype%20027%20in%20Europe,%202008&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Kuijper,%20E%20J&rft.date=2008-07-31&rft.volume=13&rft.issue=31&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/ese.13.31.18942-en&rft_dat=%3Cproquest_cross%3E69488104%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69488104&rft_id=info:pmid/18761903&rfr_iscdi=true |